Skip to main content
Log in

New oily agents for targeting chemoembolization for hepatocellular carcinoma

  • Laboratory Investigation
  • Published:
CardioVascular and Interventional Radiology Aims and scope Submit manuscript

Abstract

Purpose: The evaluation of new oily agents for targeting chemoembolization for hepatocellular carcinoma.

Methods: Five types of oily preparation were injected into the hepatic artery of 54 rabbits inoculated with VX2 carcinoma cells in order to evaluate (1) the safety of these preparations, (2) their histologic distribution and the amount of agents remaining at tumor sites, and (3) computed tomographic (CT) images obtained. Of these preparations, three were made by mixing non-iodinated poppy seed oil and a thickener and then adjusted to have a viscosity lower than, equal to, or higher than that of lipiodol. A fourth preparation was a mixture of lipiodol and a thickener with a higher viscosity than lipiodol alone, and the fifth preparation are lipiodol alone.

Results: (1) No injury to the hepatic parenchyma was observed hematologically or histologically. (2) With increase in the viscosity, a significantly larger amount of agent remained at the tumor site. No agent was present at normal sites 14 days after intraarterial injection, regardless of which preparation was given. (3) On CT scans following intraarterial injection, tumor cells were visibly deeply stained in the non-iodinated preparation groups, while the lipiodol groups were not evaluable because of excessively high attenuation.

Conclusion: The non-iodinated oily preparations and highly viscous oily preparations developed in the present study were more useful than lipiodol for treatment of hepatic tumors.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  1. Konno T, Maeda H, Iwaki K (1984) Selective targeting of anticancer drug and simultaneous image enhancement in solid tumor by arterially administered lipid contrast medium. Cancer 54:2367–2374

    Article  PubMed  CAS  Google Scholar 

  2. Konno T (1990) Targeting cancer chemotherapeutic agents by use of lipiodol contrast medium. Cancer 66:1897–1903

    Article  PubMed  CAS  Google Scholar 

  3. Konno T, Maeda H, Iwaki K (1983) Effect of arterial administration of high-molecular-weight anticancer agent SMANCS with lipid lymphographic agent on hepatoma: A preliminary report. Eur J Cancer Clin Oncol 19:1053–1065

    Article  PubMed  CAS  Google Scholar 

  4. Furuta T, Kanematsu T, Kakizoe S (1988) Selective effect of doxorubicin suspended in lipiodol on VX2 carcinoma in rabbits. J Surg Oncol 39:235–240

    Article  Google Scholar 

  5. Ohsumi M, Koitabashi H, Nagamachi Y, Iijima T (1992) Effect of lipiodol-cisplatinum arterial infusion chemotherapy on cellular immunity. Jpn J Cancer Chemother 19:327–331

    CAS  Google Scholar 

  6. Iwai K, Maeda H, Konno T, Matsumura Y, Yamashita R, Yamasaki K, Hirayama S, Miyauti Y (1987) Tumor targeting by arterial administration of lipids: Rabbit model with VX2 carcinoma in the liver. Anticancer Res 7:321–328

    PubMed  CAS  Google Scholar 

  7. Sato M, Kishi K, Shioyama Y, Tsuda M, Terada M, Tanaka H, Nakatani K, Sonomura T, Maeda M, Daimon M, Hamachi J, Kawabata M, Yamada R (1990) Effects of experimental hepatic artery embolization with lipiodol and gelatin sponge on liver tissue. Nippon Act Radiol 50:107–113

    CAS  Google Scholar 

  8. Matsuo N, Utida H, Soda S, Ohshima M, Nakano H, Oishi H, Nagano N, Kitamura I, Nishimura Y, Nishimine K, Yoshioka T (1990) Histopathological study of resected specimens after segmental Lp-TAE using lipiodol mixed with anticancer agent for hepatocellular carcinoma: Anti-tumor effect and influence on non-tumor area. Acta Hepatol Japon 31:1084–1093

    Google Scholar 

  9. Konno T (1992) Targeting chemotherapy for hepatoma: Arterial administration of anticancer drugs dissolved in lipiodol. Eur J Cancer 28:403–409

    Article  PubMed  CAS  Google Scholar 

  10. Nakamura H, Hashimoto T, Taguchi T, Oi H, Inoue K, Seki K, Mizumoto S, Tsukaguti I, Arai Y, Sawada S (1987) Oily chemoembolization of hepatoma. Jpn J Cancer Chemother 14:381–387

    CAS  Google Scholar 

  11. Segawa T, Izawa K, Tokunaga S, Ura K, Matsumoto T, Eto T, Motoshima K, Tsunoda T, Tsuchiya R (1991) Evaluation of preoperative CT findings after transcatheter arterial embolization using lipiodol in hepatocellular carcinoma. Jpn J Gastroenterol Surg 24:51–58

    Google Scholar 

  12. Koganemaru F, Okazaki M, Higashihara H, Higuchi T (1990) The evaluation of the effect of embolization using lipiodol for hepatocellular carcinoma in 59 resected cases. Diagn Imaging Abdomen 10:595–602

    Google Scholar 

  13. Yoshioka H, Nakagawa K, Shindou H, Ono Y, Kawakami A, Mabuchin N, Arita S, Fujii K, Yoshida A, Hamada T, Ishida O (1989) MR imaging of hepatocellular carcinoma following transcatheter hepatic chemo-embolization. Nippon Act Radiol 49:119–127

    CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Hamuro, M., Nakamura, K., Sakai, Y. et al. New oily agents for targeting chemoembolization for hepatocellular carcinoma. Cardiovasc Intervent Radiol 22, 130–134 (1999). https://doi.org/10.1007/s002709900348

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1007/s002709900348

Key words

Navigation